Dipl.-Ing. Dr. Stephan Harm

Donau-Universität Krems

Stephan Harm

Dipl.-Ing. Dr. Stephan Harm

Zentrum für Biomedizinische Technologie

Publikationen (Auszug Forschungs­datenbank)

Harm, S.; Schildböck, C.; Hartmann, J. (2019). Cytokine removal in extracorporeal blood purification: An in vitro study. Blood Purification, in press: 1-11

Gubensek, J.; Strobl, K.; Harm, S.; Weiss, R.; Eichhorn, T.; Buturovic-Ponikvar, J.; Weber, V.; Hartmann, J. (2018). Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup. PLoS ONE, 13(6):e0199204: doi: 10.1371/journal.pone.0199204

Harm, S.; Schildböck, C.; Hartmann, J. (2018). Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification. PLoS One, Jan 24;13(1): 10.1371/journal.pone.0191741

Eichhorn, T.; Hartmann, J.; Harm, S.; Linsberger, I.; König, F.; Valicek, G.; Miestinger, G.; Hörmann, C.; Weber, V. (2017). Clearance of selected cytokines with continuous veno-venous hemodialysis using Ultraflux EMiC2 versus Ultraflux AV1000S. Blood Purification, 44(4): 260-266

Hartmann, J.; Harm, S. (2017). A new integrated technique for the supportive treatment of sepsis. International Journal of Artificial Organs, 40(1): 4-8

Hartmann, J.; Harm, S. (2017). Removal of bile acids by extracorporeal therapies: an in vitro study. International Journal of Artificial Organs, doi: 10.5301/ijao.5000643: doi: 10.5301/ijao.5000643

Strobl, K.; Harm, S.; Weber, V.; Hartmann, J. (2017). The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. International Journal of Artificial Organs, 40(1): 15-21

Harm, S.; Hartmann, J. (2017). Removal of stabilizers from human serum albumin by nanostructured adsorbents. BioNanoMed Congress, March 2017, Krems, Austria

Hartmann, J.; Harm, S. (2017). Cytokine induction in human blood by fractionated bacterial lysates. BioNanoMed Congress, March 2017, Krems, Austria

Harm, S.; Gabor, F.; Hartmann, J. (2016). Low-Dose Polymyxin: an Option for Therapy of Gram-Negative Sepsis. Innate Immunity, 2016: 274-283

Harm, S.; Gruber, A.; Gabor, F.; Hartmann, J. (2016). Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification. Blood Purification, 2016(41): 55-63

Harm, S.; Hartmann, J. (2016). Polymyxin-Coated Nanostructured Materials: An Option for Sepsis Treatment. Journal of Nanomaterials & Molecular Nanotechnology, 10.4172/2324-8777.S4-003

Harm, S.; Gabor, F.; Hartmann, J. (2015). Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model. Journal of Immunology Research, Vol. 2015, Article ID 484736

Harm, S.; Gabor, F.; Hartmann, J. (2015). In vitro characterization of a new adsorbent for cytokines in extracorporeal blood purification. Shock, 44 Suppl 2:9

Harm S., Falkenhagen D., Hartmann J. (2014). Endotoxin adsorbents in extracorporeal blood purification: Do they fulfill expectations? The International journal of artificial organs, 04/2014, 37(3), DOI:10.5301/ijao.5000304: 222

Harm S.; Falkenhagen D.; Hartmann J. (2014). Endotoxin Adsorbents in Extracorporeal Blood Purification – Do They Fulfill The Expectations? Int J Art Org, Vol. 37, Issue 3: 222-232

Harm, S.; Falkenhagen, D.; Hartmann, J. (2014). Pore size – a key property for selective toxin removal in blood purification. Int J Art Org, DOI:10.5301/ijao.5000354: 668-678

Hartmann, J.; Beyer, R.; Harm, S. (2014). Effective Removal of Estrogens from Drinking Water and Wastewater by Adsorption Technology. Environmental Processes, 2014, 1: 87-94

Tripisciano, C.; Eichhorn, T.; Harm, S.; Weber, V. (2014). Adsorption of the Inflammatory Mediator High Mobility Group Box 1 by Polymers with Different Charge and Porosity. BioMed Research International, Article ID 238160

Hartmann, J.; Strobl, K.; Falkenhagen, D.; Harm, S. (2014). New Aspects for the Extracorporeal Treatment of Sepsis. Lecture Notes of the ICB 2014, Advances in Membrane and Adsorber Technology in Life Sciences, Warsaw: 69-74

Mehr laden
von

Patente (Auszug Forschungs­datenbank)

Dosieranleitung für endotoxinbildende Lipopeptide

Dosing instructions for endotoxin-binding lipopeptides

Zentrum für Biomedizinische Technologie

Patent-Nr: WO2014001444A1, Status: Erteilung

Ass.Prof. Dr. Jens Hartmann, Dipl.-Ing. Dr. Martin Brandl, Dipl.-Ing. Dr. Stephan Harm

Zum Anfang der Seite

 

Zum Glossar

Diese Website verwendet Cookies zur Verbesserung Ihrer Nutzererfahrung, für analytische Zwecke zur Optimierung unserer Systeme und für Marketingmaßnahmen. Indem Sie auf „OK" klicken bzw. die Website weiter verwenden, stimmen Sie der Cookie-Nutzung zu. Mehr Information zum Datenschutz.

OK